NIH Grant-Board Fight: White House Drops the Politicized Grantmaking EO After Collins-Led Bipartisan Pushback
The White House is scrapping the executive order that would have created a board of political appointees — including OMB Director Russ Vought and NIH Director Jay Bhattacharya, required to decide by unanimous vote — with veto power over NIH grant awards1. Roll Call, Sept. 23, 2026: "The White House is scrapping plans for an executive order that would give the Trump administration more control over grantmaking at the National Institutes of Health234, a person familiar with the matter said Wednesday." Semafor first reported the retreat; STAT reported the plan "appears 'dead'." No official White House announcement has been made, and one source told Semafor a pared-back order could return after the midterms.
The retreat followed Sen. Susan Collins's (R-ME) Sept. 22 letter to Vought and Bhattacharya: "I urge you not to move forward with this proposal, which would undermine the intent of the CR provision and more important, the Federal government's objective of funding biomedical research projects based on scientific merit and value rather than political ideology... If the administration seeks additional reforms of NIH, I urge you to submit a legislative proposal to Congress rather than pursue an executive order." The CR signed Sept. 2 separately delays the companion "Uniform Guidance" rule (political review of discretionary grants, expanded "for convenience" terminations) until Dec. 11. Sen. Patty Murray (D-WA) welcomed the news: "It shouldn't take public outcry to prevent President Trump and [OMB director] Russ Vought from laying waste to the NIH and defunding lifesaving research because they think it's 'woke' or want to extort a university."
Why it matters: a rare visible retreat of executive consolidation under appropriations-committee pressure — in the same week the administration pressed ahead with the $810M pocket rescission (Pocket Rescission: GAO Says Illegal (Again), First Lawsuit Filed — as the $810M Lapses). The contrast shows where Congress's leverage still bites (an appropriator chair whose committee funds NIH's ~$48.7B budget) and where the administration calculates it can act unilaterally over bipartisan objection.
-
An instance of Unitary executive controls convert merit-based federal grants into tools of partisan compliance. — The proposed political veto over merit-reviewed NIH grants is exactly the conversion of discretionary awards into partisan compliance tools, abandoned here under appropriations pressure. ↩︎
-
An instance of Power grabs are formally rescinded only where defiance carries an institutional price. — The retreat came only after the appropriations chair controlling NIH's budget objected — formal abandonment exactly where defiance carries an institutional price. ↩︎
-
An instance of Each repelled power grab is being converted into a permanent institutional lock. — Appropriators forced grant politics back through the legislative channel where congressional leverage still bites. ↩︎
-
An instance of Bipartisan legislative coalitions are the final defensive buffer against unilateral department closures. — A single appropriations chair's letter kills the politicized grantmaking EO, showing bipartisan congressional leverage still functioning as the final buffer. ↩︎